11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $71000 | -$4M | -207.0% | -30712.7% | -$5M | — | $2M |
| 2024 | $3M | $32M | -61.6% | -1485.4% | -$34M | — | $1M |
| 2023 | $2M | -$66M | -161.8% | -2805.7% | -$52M | — | $20M |
| 2022 | $377000 | -$89M | -858.6% | -24161.0% | -$73M | — | $40M |
| 2021 | $500000 | -$50M | -17.0% | -10878.6% | -$42M | — | $77M |
| 2020 | — | -$34M | — | — | -$22M | — | $17M |
| 2019 | — | -$16M | — | — | -$13M | — | $6M |
| 2018 | — | -$18M | — | — | -$9M | — | $8M |
| 2017 | — | -$10M | — | — | -$7M | — | $2M |
| 2016 | — | -$6M | — | — | — | — | $585680 |
| 2015 | — | -$2M | — | — | — | — | $767268 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $22000 | -$60000 | -340.9% | -36522.7% | -$3M | — | $6M |
| Dec '25 | $52000 | -$1M | -63.5% | -13082.7% | -$2M | — | $2M |
| Sep '25 | $5000 | -$5M | -1000.0% | -96880.0% | -$899000 | — | — |
| Jun '25 | $6000 | -$12M | -583.3% | -78583.3% | -$1M | — | — |
| Mar '25 | $8000 | $19M | -350.0% | -68075.0% | -$2M | — | — |
| Dec '24 | $10000 | $1M | -380.0% | -51870.0% | $90000 | — | $1M |
| Sep '24 | $996000 | $64M | -38.7% | -1162.4% | -$9M | — | $765000 |
| Jun '24 | $979000 | -$11M | -70.2% | -1397.8% | -$12M | — | $25M |
| Mar '24 | $1M | -$15M | -72.7% | -1389.7% | -$13M | — | $26M |
| Dec '23 | $1M | -$14M | -53.6% | -1561.8% | -$12M | — | $20M |
| Sep '23 | $791000 | -$18M | -124.9% | -1963.1% | -$11M | — | $26M |
| Jun '23 | $166000 | -$15M | -915.1% | -9930.1% | -$13M | — | $37M |
| Mar '23 | $446000 | -$18M | -201.8% | -4574.2% | -$16M | — | $49M |
| Dec '22 | $112000 | -$20M | -1344.6% | -21965.2% | -$17M | — | $40M |
| Sep '22 | $76000 | -$26M | -2039.5% | -30746.1% | -$20M | — | $57M |
| Jun '22 | $0 | -$26M | — | — | -$23M | — | $65M |
| Mar '22 | $189000 | -$17M | -95.2% | -10388.9% | -$13M | — | $65M |
| Dec '21 | $300000 | -$17M | -47.0% | -6559.7% | -$18M | — | $77M |
| Sep '21 | $200000 | -$12M | 28.0% | -6834.0% | -$8M | — | $37M |
| Jun '21 | — | -$11M | — | — | -$7M | — | $43M |
How the market has priced PAVM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, PAVmed Inc.'s revenue has declined 38.6% per year. These are computed facts, not advice.
As of FY2025, PAVmed Inc. reported — of total debt against $2M of cash; operating income covered interest expense -1038.4×.
In FY2025, gross margin was -207.0%, operating margin -30712.7%, and net margin -5315.5%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.